Interleukin-4 and interleukin-13: Bidirectional effects on human osteoclast formation

Bone

Volumn 29, Issue 3, 2001, Pages 203-208

  Scopes, J ^b   Massey, H M ^a   Ebrahim, H ^b   Horton, M A ^c   Flanagan, A M ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Human; Interleukin 13; Interleukin 4; Monocytes macrophages; Osteoclast; Th1 Th2

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; LIGAND;

ARTICLE; BONE DEVELOPMENT; CELL ACTIVATION; CELL COUNT; CELL CULTURE; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPHOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; OSTEOCLAST; OSTEOLYSIS;

EID: 0034847045     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00500-2     Document Type: Article

References (39)

1. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
2. Review - Systemic mastocytosis and other cell neoplasms
3. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4 and interleukin-10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritis
4. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor
5. Effects of IL-13 on phenotype, cytokine production, and cytokine function, on human monocytes
6. Review. Recombinant cytotoxins specific for cancer cells
7. Modulation of murine macrophage function by IL-13
8. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines
9. Mast cell proliferation in postmenopausal osteoporosis
10. Study of the non-resorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: A new approach to investigating pathogenesis
11. TGF-β1 and IFN-γ direct macrophage activation by TNF-α to osteoclastic or cytocidal phenotype
12. A role for TGFβ(1) in osteoclast differentiation and survival
13. Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon-gamma
14. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
15. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor
16. A new cytokine-dependent monoblastic cell line with t(9;11)(p22;q23) differentiates to macrophages with macrophage colony-stimulating factor (M-CSF) and to osteoclast-like cell with M-CSF and interleukin-4
17. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase
18. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
19. Interleukin-4, interferon-γ, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages
20. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
21. Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: Differences in osteoclast CD11c/CD18 integrin expression
22. Mast cells accumulate in rat bone marrow after ovariectomy
23. Regulation of immune responses by TGF-β
24. Clinical and immunological aspects of hyperimmunoglobulin E syndrome
25. Osteoporosis induced in mice by overproduction of interleukin 4
26. Effects of interleukin 3 and granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue
27. Human osteoclasts derive from CD14-positive monocytes
28. Transforming growth factor-β1 stimulates the osteoclast-forming potential of the haemopoietic precursor in peripheral blood cells in a lymphocyte-rich microenvironment
29. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
30. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells
31. Mast cells
32. The IL-4 receptor: Signaling mechanisms and biological functions
33. Trafficking of matrix collagens through bone-resorbing osteoclasts
34. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts
35. Macrophage-colony stimulating factor (M-CSF) induces substantial osteoclast formation in human bone-marrow cultures
36. TGF-β enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF
37. Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells
38. TRANCE is a novel ligand of the tumour necrosis factor receptor family that activates c-jun N-terminal kinase in T cells
39. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factory and is identical to TRANCE/RANKL